Computational Models for Human and Animal Hepatotoxicity with a Global Application Scope

Hepatic toxicity is a key concern for novel pharmaceutical drugs since it is difficult to anticipate in preclinical models, and it can originate from pharmacologically unrelated drug effects, such as pathway interference, metabolism, and drug accumulation. Because liver toxicity still ranks among th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chemical research in toxicology 2016-05, Vol.29 (5), p.757-767
Hauptverfasser: Mulliner, Denis, Schmidt, Friedemann, Stolte, Manuela, Spirkl, Hans-Peter, Czich, Andreas, Amberg, Alexander
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 767
container_issue 5
container_start_page 757
container_title Chemical research in toxicology
container_volume 29
creator Mulliner, Denis
Schmidt, Friedemann
Stolte, Manuela
Spirkl, Hans-Peter
Czich, Andreas
Amberg, Alexander
description Hepatic toxicity is a key concern for novel pharmaceutical drugs since it is difficult to anticipate in preclinical models, and it can originate from pharmacologically unrelated drug effects, such as pathway interference, metabolism, and drug accumulation. Because liver toxicity still ranks among the top reasons for drug attrition, the reliable prediction of adverse hepatic effects is a substantial challenge in drug discovery and development. To this end, more effort needs to be focused on the development of improved predictive in-vitro and in-silico approaches. Current computational models often lack applicability to novel pharmaceutical candidates, typically due to insufficient coverage of the chemical space of interest, which is either imposed by size or diversity of the training data. Hence, there is an urgent need for better computational models to allow for the identification of safe drug candidates and to support experimental design. In this context, a large data set comprising 3712 compounds with liver related toxicity findings in humans and animals was collected from various sources. The complex pathology was clustered into 21 preclinical and human hepatotoxicity endpoints, which were organized into three levels of detail. Support vector machine models were trained for each endpoint, using optimized descriptor sets from chemometrics software. The optimized global human hepatotoxicity model has high sensitivity (68%) and excellent specificity (95%) in an internal validation set of 221 compounds. Models for preclinical endpoints performed similarly. To allow for reliable prediction of “truly external” novel compounds, all predictions are tagged with confidence parameters. These parameters are derived from a statistical analysis of the predictive probability densities. The whole approach was validated for an external validation set of 269 proprietary compounds. The models are fully integrated into our early safety in-silico workflow.
doi_str_mv 10.1021/acs.chemrestox.5b00465
format Article
fullrecord <record><control><sourceid>acs_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_acs_chemrestox_5b00465</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>c832454329</sourcerecordid><originalsourceid>FETCH-LOGICAL-a402t-287a9dcd0eef5d9b07078e9f79873fda1b1f407478884e4a11aadea45290d0a3</originalsourceid><addsrcrecordid>eNqFkEFOwzAQRS0EoqVwhcoXSBm7TuwsqwpapCIWdNFdNIkdNVUSR7Ej6O1xaYElq1n8eX9Gj5ApgxkDzh6xcLNib5reOG8_Z3EOIJL4ioxZzCGKgcE1GYNK5xHnajcid84dAFhg5S0Z8SRlImbJmOyWtukGj76yLdb01WpTO1ranq6HBluKraaLtmpCtjYdehuuVUXlj_Sj8nuKdFXbPISLrqur4ruGvhe2M_fkpsTamYfLnJDt89N2uY42b6uX5WIToQDuI64kprrQYEwZ6zQHCVKZtJSpkvNSI8tZKUAKqZQSRiBjiNqgiHkKGnA-Icm5tuitc70ps64P3_bHjEF2MpUFU9mfqexiKoDTM9gNeWP0L_ajJizw88Kp4GCHPvhx_7V-ASU6e8g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Computational Models for Human and Animal Hepatotoxicity with a Global Application Scope</title><source>MEDLINE</source><source>ACS Publications</source><creator>Mulliner, Denis ; Schmidt, Friedemann ; Stolte, Manuela ; Spirkl, Hans-Peter ; Czich, Andreas ; Amberg, Alexander</creator><creatorcontrib>Mulliner, Denis ; Schmidt, Friedemann ; Stolte, Manuela ; Spirkl, Hans-Peter ; Czich, Andreas ; Amberg, Alexander</creatorcontrib><description>Hepatic toxicity is a key concern for novel pharmaceutical drugs since it is difficult to anticipate in preclinical models, and it can originate from pharmacologically unrelated drug effects, such as pathway interference, metabolism, and drug accumulation. Because liver toxicity still ranks among the top reasons for drug attrition, the reliable prediction of adverse hepatic effects is a substantial challenge in drug discovery and development. To this end, more effort needs to be focused on the development of improved predictive in-vitro and in-silico approaches. Current computational models often lack applicability to novel pharmaceutical candidates, typically due to insufficient coverage of the chemical space of interest, which is either imposed by size or diversity of the training data. Hence, there is an urgent need for better computational models to allow for the identification of safe drug candidates and to support experimental design. In this context, a large data set comprising 3712 compounds with liver related toxicity findings in humans and animals was collected from various sources. The complex pathology was clustered into 21 preclinical and human hepatotoxicity endpoints, which were organized into three levels of detail. Support vector machine models were trained for each endpoint, using optimized descriptor sets from chemometrics software. The optimized global human hepatotoxicity model has high sensitivity (68%) and excellent specificity (95%) in an internal validation set of 221 compounds. Models for preclinical endpoints performed similarly. To allow for reliable prediction of “truly external” novel compounds, all predictions are tagged with confidence parameters. These parameters are derived from a statistical analysis of the predictive probability densities. The whole approach was validated for an external validation set of 269 proprietary compounds. The models are fully integrated into our early safety in-silico workflow.</description><identifier>ISSN: 0893-228X</identifier><identifier>EISSN: 1520-5010</identifier><identifier>DOI: 10.1021/acs.chemrestox.5b00465</identifier><identifier>PMID: 26914516</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Animals ; Area Under Curve ; Computer Simulation ; Dose-Response Relationship, Drug ; Humans ; Liver - drug effects ; Toxicity Tests</subject><ispartof>Chemical research in toxicology, 2016-05, Vol.29 (5), p.757-767</ispartof><rights>Copyright © 2016 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a402t-287a9dcd0eef5d9b07078e9f79873fda1b1f407478884e4a11aadea45290d0a3</citedby><cites>FETCH-LOGICAL-a402t-287a9dcd0eef5d9b07078e9f79873fda1b1f407478884e4a11aadea45290d0a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.chemrestox.5b00465$$EPDF$$P50$$Gacs$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.chemrestox.5b00465$$EHTML$$P50$$Gacs$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26914516$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mulliner, Denis</creatorcontrib><creatorcontrib>Schmidt, Friedemann</creatorcontrib><creatorcontrib>Stolte, Manuela</creatorcontrib><creatorcontrib>Spirkl, Hans-Peter</creatorcontrib><creatorcontrib>Czich, Andreas</creatorcontrib><creatorcontrib>Amberg, Alexander</creatorcontrib><title>Computational Models for Human and Animal Hepatotoxicity with a Global Application Scope</title><title>Chemical research in toxicology</title><addtitle>Chem. Res. Toxicol</addtitle><description>Hepatic toxicity is a key concern for novel pharmaceutical drugs since it is difficult to anticipate in preclinical models, and it can originate from pharmacologically unrelated drug effects, such as pathway interference, metabolism, and drug accumulation. Because liver toxicity still ranks among the top reasons for drug attrition, the reliable prediction of adverse hepatic effects is a substantial challenge in drug discovery and development. To this end, more effort needs to be focused on the development of improved predictive in-vitro and in-silico approaches. Current computational models often lack applicability to novel pharmaceutical candidates, typically due to insufficient coverage of the chemical space of interest, which is either imposed by size or diversity of the training data. Hence, there is an urgent need for better computational models to allow for the identification of safe drug candidates and to support experimental design. In this context, a large data set comprising 3712 compounds with liver related toxicity findings in humans and animals was collected from various sources. The complex pathology was clustered into 21 preclinical and human hepatotoxicity endpoints, which were organized into three levels of detail. Support vector machine models were trained for each endpoint, using optimized descriptor sets from chemometrics software. The optimized global human hepatotoxicity model has high sensitivity (68%) and excellent specificity (95%) in an internal validation set of 221 compounds. Models for preclinical endpoints performed similarly. To allow for reliable prediction of “truly external” novel compounds, all predictions are tagged with confidence parameters. These parameters are derived from a statistical analysis of the predictive probability densities. The whole approach was validated for an external validation set of 269 proprietary compounds. The models are fully integrated into our early safety in-silico workflow.</description><subject>Animals</subject><subject>Area Under Curve</subject><subject>Computer Simulation</subject><subject>Dose-Response Relationship, Drug</subject><subject>Humans</subject><subject>Liver - drug effects</subject><subject>Toxicity Tests</subject><issn>0893-228X</issn><issn>1520-5010</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>N~.</sourceid><sourceid>EIF</sourceid><recordid>eNqFkEFOwzAQRS0EoqVwhcoXSBm7TuwsqwpapCIWdNFdNIkdNVUSR7Ej6O1xaYElq1n8eX9Gj5ApgxkDzh6xcLNib5reOG8_Z3EOIJL4ioxZzCGKgcE1GYNK5xHnajcid84dAFhg5S0Z8SRlImbJmOyWtukGj76yLdb01WpTO1ranq6HBluKraaLtmpCtjYdehuuVUXlj_Sj8nuKdFXbPISLrqur4ruGvhe2M_fkpsTamYfLnJDt89N2uY42b6uX5WIToQDuI64kprrQYEwZ6zQHCVKZtJSpkvNSI8tZKUAKqZQSRiBjiNqgiHkKGnA-Icm5tuitc70ps64P3_bHjEF2MpUFU9mfqexiKoDTM9gNeWP0L_ajJizw88Kp4GCHPvhx_7V-ASU6e8g</recordid><startdate>20160516</startdate><enddate>20160516</enddate><creator>Mulliner, Denis</creator><creator>Schmidt, Friedemann</creator><creator>Stolte, Manuela</creator><creator>Spirkl, Hans-Peter</creator><creator>Czich, Andreas</creator><creator>Amberg, Alexander</creator><general>American Chemical Society</general><scope>N~.</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20160516</creationdate><title>Computational Models for Human and Animal Hepatotoxicity with a Global Application Scope</title><author>Mulliner, Denis ; Schmidt, Friedemann ; Stolte, Manuela ; Spirkl, Hans-Peter ; Czich, Andreas ; Amberg, Alexander</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a402t-287a9dcd0eef5d9b07078e9f79873fda1b1f407478884e4a11aadea45290d0a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Area Under Curve</topic><topic>Computer Simulation</topic><topic>Dose-Response Relationship, Drug</topic><topic>Humans</topic><topic>Liver - drug effects</topic><topic>Toxicity Tests</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mulliner, Denis</creatorcontrib><creatorcontrib>Schmidt, Friedemann</creatorcontrib><creatorcontrib>Stolte, Manuela</creatorcontrib><creatorcontrib>Spirkl, Hans-Peter</creatorcontrib><creatorcontrib>Czich, Andreas</creatorcontrib><creatorcontrib>Amberg, Alexander</creatorcontrib><collection>American Chemical Society (ACS) Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Chemical research in toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mulliner, Denis</au><au>Schmidt, Friedemann</au><au>Stolte, Manuela</au><au>Spirkl, Hans-Peter</au><au>Czich, Andreas</au><au>Amberg, Alexander</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Computational Models for Human and Animal Hepatotoxicity with a Global Application Scope</atitle><jtitle>Chemical research in toxicology</jtitle><addtitle>Chem. Res. Toxicol</addtitle><date>2016-05-16</date><risdate>2016</risdate><volume>29</volume><issue>5</issue><spage>757</spage><epage>767</epage><pages>757-767</pages><issn>0893-228X</issn><eissn>1520-5010</eissn><abstract>Hepatic toxicity is a key concern for novel pharmaceutical drugs since it is difficult to anticipate in preclinical models, and it can originate from pharmacologically unrelated drug effects, such as pathway interference, metabolism, and drug accumulation. Because liver toxicity still ranks among the top reasons for drug attrition, the reliable prediction of adverse hepatic effects is a substantial challenge in drug discovery and development. To this end, more effort needs to be focused on the development of improved predictive in-vitro and in-silico approaches. Current computational models often lack applicability to novel pharmaceutical candidates, typically due to insufficient coverage of the chemical space of interest, which is either imposed by size or diversity of the training data. Hence, there is an urgent need for better computational models to allow for the identification of safe drug candidates and to support experimental design. In this context, a large data set comprising 3712 compounds with liver related toxicity findings in humans and animals was collected from various sources. The complex pathology was clustered into 21 preclinical and human hepatotoxicity endpoints, which were organized into three levels of detail. Support vector machine models were trained for each endpoint, using optimized descriptor sets from chemometrics software. The optimized global human hepatotoxicity model has high sensitivity (68%) and excellent specificity (95%) in an internal validation set of 221 compounds. Models for preclinical endpoints performed similarly. To allow for reliable prediction of “truly external” novel compounds, all predictions are tagged with confidence parameters. These parameters are derived from a statistical analysis of the predictive probability densities. The whole approach was validated for an external validation set of 269 proprietary compounds. The models are fully integrated into our early safety in-silico workflow.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>26914516</pmid><doi>10.1021/acs.chemrestox.5b00465</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0893-228X
ispartof Chemical research in toxicology, 2016-05, Vol.29 (5), p.757-767
issn 0893-228X
1520-5010
language eng
recordid cdi_crossref_primary_10_1021_acs_chemrestox_5b00465
source MEDLINE; ACS Publications
subjects Animals
Area Under Curve
Computer Simulation
Dose-Response Relationship, Drug
Humans
Liver - drug effects
Toxicity Tests
title Computational Models for Human and Animal Hepatotoxicity with a Global Application Scope
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T18%3A13%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Computational%20Models%20for%20Human%20and%20Animal%20Hepatotoxicity%20with%20a%20Global%20Application%20Scope&rft.jtitle=Chemical%20research%20in%20toxicology&rft.au=Mulliner,%20Denis&rft.date=2016-05-16&rft.volume=29&rft.issue=5&rft.spage=757&rft.epage=767&rft.pages=757-767&rft.issn=0893-228X&rft.eissn=1520-5010&rft_id=info:doi/10.1021/acs.chemrestox.5b00465&rft_dat=%3Cacs_cross%3Ec832454329%3C/acs_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/26914516&rfr_iscdi=true